Mol Med. 2016 Dec;22:713-723. doi: 10.2119/molmed.2016.00041. Epub 2016 Sep 29.
RhoA/ROCK signaling regulates TGFβ-induced epithelial-mesenchymal transition of lens epithelial cells through MRTF-A.
Molecular medicine (Cambridge, Mass.)
Anna Korol, Aftab Taiyab, Judith A West-Mays
Affiliations
Affiliations
- Department of Pathology and Molecular Medicine, McMaster University Health Science Centre, Rm 4H25, 1200 Main St. West. Hamilton, ON, L8N 3Z5, Canada.
PMID: 27704140
PMCID: PMC5135079 DOI: 10.2119/molmed.2016.00041
Abstract
Transforming growth factor (TGF)-β-induced epithelial-mesenchymal transition (EMT) leads to the formation of ocular fibrotic pathologies, such as anterior subcapsular cataract and posterior capsule opacification. Remodeling of the actin cytoskeleton, mediated by the Rho family of GTPases, plays a key role in EMT, however, how actin dynamics affect downstream markers of EMT has not been fully determined. Our previous work suggests that myocardin related transcription factor A (MRTF-A), an actin-binding protein, might be an important mediator of TGFβ-induced EMT in lens epithelial cells. The aim of the current study was to determine the requirement of RhoA/ROCK signaling in mediating TGFβ-induced nuclear accumulation of MRTF-A, and ultimate expression of α-smooth muscle actin (αSMA), a marker of a contractile, myofibroblast phenotype. Using rat lens epithelial explants, we demonstrate that ROCK inhibition using Y-27632 prevents TGFβ-induced nuclear accumulation of MRTF-A, E-cadherin/β-catenin complex disassembly, and αSMA expression. Using a novel inhibitor specifically targeting MRTF-A signaling, CCG-203971, we further demonstrate the requirement of MRTF-A nuclear localization and activity in the induction of αSMA expression. Overall, our findings suggest that TGFβ-induced cytoskeletal reorganization through RhoA/ROCK/MRTF-A signaling is critical to EMT of lens epithelial cells.
Keywords: Cataract; beta catenin; cytoskeleton; fibrosis; myofibroblast
References
- Br J Ophthalmol. 2002 Feb;86(2):220-6 - PubMed
- Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3450-60 - PubMed
- Br J Ophthalmol. 2012 May;96(5):614-8 - PubMed
- J Cataract Refract Surg. 2010 Oct;36(10):1768-74 - PubMed
- Optometry. 2001 Feb;72(2):94-102 - PubMed
- Inflamm Bowel Dis. 2014 Jan;20(1):154-65 - PubMed
- PLoS One. 2013 Dec 10;8(12):e83188 - PubMed
- Dev Dyn. 2006 Jun;235(6):1589-98 - PubMed
- J Cell Sci. 2007 May 15;120(Pt 10):1801-9 - PubMed
- Mol Cancer Ther. 2007 Aug;6(8):2249-60 - PubMed
- Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5736-5747 - PubMed
- J Med Assoc Thai. 2006 Oct;89(10):1766-9 - PubMed
- Ophthalmology. 2010 Aug;117(8):1506-11 - PubMed
- Am J Physiol Renal Physiol. 2008 May;294(5):F1116-28 - PubMed
- Invest Ophthalmol Vis Sci. 2001 Apr;42(5):1029-37 - PubMed
- Nat Cell Biol. 2002 Jun;4(6):408-15 - PubMed
- Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1709-13 - PubMed
- J Cell Physiol. 2015 Aug;230(8):1829-39 - PubMed
- Beilstein J Org Chem. 2013 May 21;9:966-73 - PubMed
- Cell. 2003 May 2;113(3):329-42 - PubMed
- Mol Biol Cell. 2001 Jan;12(1):27-36 - PubMed
- Cornea. 2014 Nov;33 Suppl 11:S25-31 - PubMed
- Am J Pathol. 2013 Feb;182(2):388-400 - PubMed
- Mol Biol Cell. 2007 Mar;18(3):1083-97 - PubMed
- Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29 - PubMed
- Curr Eye Res. 2001 Jun;22(6):470-4 - PubMed
- Exp Eye Res. 2009 Feb;88(2):257-69 - PubMed
- Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1170-80 - PubMed
- Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1399-409 - PubMed
- Am J Pathol. 2006 Jan;168(1):69-79 - PubMed
- J Cell Sci. 2008 Apr 1;121(Pt 7):1025-35 - PubMed
- EMBO Rep. 2012 Oct;13(10):900-8 - PubMed
- Cell. 2014 Jan 30;156(3):563-76 - PubMed
- Am J Ophthalmol. 1983 Jan;95(1):82-96 - PubMed
- J Cell Biol. 2007 Dec 3;179(5):1027-42 - PubMed
- Am J Physiol Renal Physiol. 2003 May;284(5):F911-24 - PubMed
- Biochem J. 2000 Jun 1;348 Pt 2:241-55 - PubMed
- Ophthalmologe. 2009 Nov;106(11):1017-21 - PubMed
- Cell Biol Int. 2007 Oct;31(10):1225-30 - PubMed
- Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1410-8 - PubMed
- Nature. 1997 Oct 30;389(6654):990-4 - PubMed
- Am J Physiol Cell Physiol. 2007 Jan;292(1):C70-81 - PubMed
- Am J Physiol Renal Physiol. 2003 Jul;285(1):F130-42 - PubMed
- Mol Vis. 2013 May 06;19:1017-28 - PubMed
- Diab Vasc Dis Res. 2016 Jan;13(1):81-92 - PubMed
- Am J Pathol. 2014 Jul;184(7):2001-12 - PubMed
- Exp Cell Res. 2014 Oct 15;328(1):164-71 - PubMed
- Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2201-11 - PubMed
- Am J Pathol. 2004 Feb;164(2):651-63 - PubMed
- J Biol Chem. 2002 Mar 22;277(12):9800-5 - PubMed
- PLoS One. 2014 Feb 18;9(2):e89016 - PubMed
- Int J Mol Med. 2013 Aug;32(2):464-8 - PubMed
- Curr Eye Res. 1994 Dec;13(12):885-90 - PubMed
- Mol Vis. 2003 Jul 17;9:329-36 - PubMed
- Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1946-53 - PubMed
- Nippon Ganka Gakkai Zasshi. 1994 May;98(5):495-500 - PubMed
- Acta Anat (Basel). 1984;119(2):106-12 - PubMed
- J Cell Biol. 2010 Jun 28;189(7):1107-15 - PubMed
- FEBS Lett. 2008 Jan 23;582(2):291-8 - PubMed
- Cells Tissues Organs. 2005;179(1-2):43-55 - PubMed
- Pharmacol Ther. 2013 Mar;137(3):352-64 - PubMed
- Integr Biol (Camb). 2015 Oct;7(10 ):1109-19 - PubMed
- Curr Med Chem. 2008;15(27):2876-85 - PubMed
- Mol Vis. 2007 Mar 27;13:457-69 - PubMed
Publication Types
Grant support